Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart

被引:180
作者
Saavedra, WF
Paolocci, N
John, MES
Skaf, MW
Stewart, GC
Xie, JS
Harrison, RW
Zeichner, J
Mudrick, D
Marbán, E
Kass, DA
Hare, JM
机构
[1] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD USA
[2] Johns Hopkins Med Inst, Inst Mol Cardiobiol, Baltimore, MD USA
关键词
xanthine oxidase; oxidative stress; nitric oxide; heart failure; ascorbate;
D O I
10.1161/hh0302.104531
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inhibition of xanthine oxidase (XO) in failing hearts improves cardiac efficiency by an unknown mechanism. We hypothesized that this energetic effect is due to reduced oxidative stress and critically depends on nitric oxide synthase (NOS) activity, reflecting a balance between generation of nitric oxide (NO) and reactive oxygen species. In dogs with pacing-induced heart failure (HF), ascorbate (1000 mg) mimicked the beneficial energetic effects of allopurinol, increasing both contractility and efficiency, suggesting an antioxidant mechanism. Allopurinol had no additive effect beyond that of ascorbate. Crosstalk between XO and NOS signaling was assessed. NOS inhibition with N-G-monomethyl-L-arginine (L-NMMA; 20 mg/kg) had no effect on basal contractility or efficiency in HF, but prevented the +26.2+/-3.5% and +66.5+/-17% enhancements of contractility and efficiency, respectively, observed with allopurinol alone. Similarly, improvements in contractility and energetics due to ascorbate were also inhibited by L-NMMA. Because of the observed NOS-XO crosstalk, we predicted that in normal hearts NOS inhibition would uncover a depression of energetics caused by XO activity. In normal conscious dogs, L-NMMA increased myocardial oxygen consumption (M(V) over dot O-2) while lowering left ventricular external work, reducing efficiency by 31.1+/-3.8% (P<0.005). Lowered efficiency was reversed by XO inhibition (allopurinol, 200 mg) or by ascorbate without affecting cardiac load or systemic hemodynamics. Single-cell immunofluorescence detected XO protein in cardiac myocytes that was enhanced in HF, consistent with autocrine signaling. These data show that both NOS and XO signaling systems participate in the regulation of myocardial mechanical efficiency and that upregulation of XO relative to NOS contributes to mechanoenergetic uncoupling in heart failure.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 50 条
[1]  
Abadeh Shahla, 1992, Biochemical Society Transactions, V20, p346S
[2]   Mitochondrial nitric oxide synthase: A ubiquitous regulator of oxidative phosphorylation? [J].
Bates, TE ;
Loesch, A ;
Burnstock, G ;
Clark, JB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (01) :40-44
[3]   Redox modulation of L-type calcium channels in ferret ventricular myocytes - Dual mechanism regulation by nitric oxide and S-nitrosothiols [J].
Campbell, DL ;
Stamler, JS ;
Strauss, HC .
JOURNAL OF GENERAL PHYSIOLOGY, 1996, 108 (04) :277-293
[4]   Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].
Cappola, TP ;
Kass, DA ;
Nelson, GS ;
Berger, RD ;
Rosas, GO ;
Kobeissi, ZA ;
Marbán, E ;
Hare, JM .
CIRCULATION, 2001, 104 (20) :2407-2411
[5]   FUNCTIONAL CONSEQUENCES OF SULFHYDRYL MODIFICATION IN THE PORE-FORMING SUBUNITS OF CARDIOVASCULAR CA2+ AND NA+ CHANNELS [J].
CHIAMVIMONVAT, N ;
OROURKE, B ;
KAMP, TJ ;
KALLEN, RG ;
HOFMANN, F ;
FLOCKERZI, V ;
MARBAN, E .
CIRCULATION RESEARCH, 1995, 76 (03) :325-334
[6]   On the mechanism by which vascular endothelial cells regulate their oxygen consumption [J].
Clementi, E ;
Brown, GC ;
Foxwell, N ;
Moncada, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1559-1562
[7]   Persistent inhibition of cell respiration by nitric oxide:: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione [J].
Clementi, E ;
Brown, GC ;
Feelisch, M ;
Moncada, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7631-7636
[8]   Enhanced expression and activity of xanthine oxidoreductase in the failing heart [J].
de Jong, JW ;
Schoemaker, RG ;
de Jonge, R ;
Bernocchi, P ;
Keijzer, E ;
Harrison, R ;
Sharma, HS ;
Ceconi, C .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (11) :2083-2089
[9]   XANTHINE OXIDOREDUCTASE ACTIVITY IN PERFUSED HEARTS OF VARIOUS SPECIES, INCLUDING HUMANS [J].
DEJONG, JW ;
VANDERMEER, P ;
NIEUKOOP, AS ;
HUIZER, T ;
STROEVE, RJ ;
BOS, E .
CIRCULATION RESEARCH, 1990, 67 (03) :770-773
[10]   Increased malondialdehyde in peripheral blood of patients with congestive heart failure [J].
DiazVelez, CR ;
GarciaCastineiras, S ;
MendozaRamos, E ;
HernandezLopez, E .
AMERICAN HEART JOURNAL, 1996, 131 (01) :146-152